Implants

Enhancing therapies across the entire spectrum of devices.

BIOTRONIK Home Monitoring^® supports all BIOTRONIK high-quality therapy devices throughout all stages of the implant's life cycle. Patient status and device status data are transmitted silently and without any patient involvement to the Home Monitoring Service Center where the information is then compiled into a comprehensive report, called the CardioReport.

In addition, BIOTRONIK Home Monitoring immediately detects clinically relevant patient events, making early detection and fast intervention possible. Unlike any other existing technology, BIOTRONIK Home Monitoring has almost no impact on the implant's battery life and overall device longevity.*
 

How BIOTRONIK Home Monitoring benefits ICD, CRT and pacemaker therapies.
 

IEGM-Online^® HD for detailed arrhythmia monitoring

BIOTRONIK Home Monitoring transmits an IEGM-Online HD of rhythm disorders, recorded before the detection of clinically relevant events. It provides the right and left ventricular as well as atrial IEGMs plus corresponding marker channels. This way the physician can quickly and accurately determine the patient's rhythm disturbance, device detection capabilities, and therapy success.
IEGM Online.
 

Ensure appropriate ICD-therapies

Prevention of inappropriate ICD therapies is of utmost importance to maintain patients' safety and quality of life. Providing comprehensive therapy monitoring capabilities, BIOTRONIK Home Monitoring helps to early and quickly identify potential causes of inappropriate ICD therapies, such as sensing problems or inadequate device programming. It thus enables immediate intervention even before the first inappropriate therapy has started, resulting in increased patient safety and improved quality of life.
 

Cardiac resynchronization therapy management

In CRT, continuous biventricular stimulation is crucial for therapy successes. For that reason, clinicians must frequently evaluate device performances and adjust programmable parameter settings to the patient's individual needs. BIOTRONIK Home Monitoring helps physicians to monitor the percentage of biventricular pacing so that adjustments to the programmable parameters can be made quickly, if needed.
 

Early detection of atrial arrhythmias

Atrial fibrillation (AF) is a common rhythm disorder that occurs in many pacemaker and ICD patients. Even in its earliest stages, sustaining AF is associated with an increased risk of severe clinical events such as stroke, inappropriate ICD therapy, and rehospitalization. Early detection of even asymptomatic AF episodes and immediate notification of the physician through BIOTRONIK Home Monitoring reduces these associated risks and enables early intervention and (patient) individualized therapy management (e.g. adaptation of medication).
 

Optimal pacemaker settings

BIOTRONIK pacemakers with Home Monitoring allow the physician to actually monitor the percentage of ventricular pacing. Utilizing that information, the physician can adjust the programmable parameters to assure appropriate ventricular pacing support without excessive pacing.
 

Optimum patient care scheduling

Home Monitoring optimizes patient care by providing all daily updated follow-up data and making it accessible at any time. By reviewing this data, the need of in person follow-ups can be estimated in advance. In specific cases, follow-ups can also be accomplished remotely. BIOTRONIK has gained FDA and CE approval for this remote system called Home Monitoring.
 

Device status monitoring

BIOTRONIK Home Monitoring indicates the Elective Replacement Indication (ERI) and all other critical device and lead related status changes. This increases patient's safety and enables the planning of unscheduled follow-ups or regular device exchange operations well in advance.

 

*Complete BIOTRONIK Home Monitoring functionality uses approximately 2% of battery power over the complete lifetime of the device, equivalent to one high energy shock in ICDs.